Gevo, Inc. (NASDAQ:GEVO - Get Free Report) has been given an average rating of "Hold" by the five ratings firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and two have given a buy recommendation to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $6.4167.
Several analysts have recently commented on GEVO shares. Wall Street Zen downgraded shares of Gevo from a "hold" rating to a "sell" rating in a research report on Saturday, March 7th. Northland Securities reaffirmed an "outperform" rating and issued a $3.00 target price on shares of Gevo in a report on Wednesday, December 31st. Finally, Weiss Ratings reiterated a "sell (d-)" rating on shares of Gevo in a research note on Thursday, January 22nd.
Read Our Latest Stock Report on GEVO
Insider Activity at Gevo
In related news, Director Gary W. Mize sold 107,100 shares of the business's stock in a transaction that occurred on Thursday, March 12th. The stock was sold at an average price of $2.33, for a total value of $249,543.00. Following the transaction, the director directly owned 281,226 shares of the company's stock, valued at approximately $655,256.58. The trade was a 27.58% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Christopher Michael Ryan sold 29,797 shares of the stock in a transaction that occurred on Tuesday, March 31st. The shares were sold at an average price of $2.96, for a total transaction of $88,199.12. Following the sale, the chief operating officer directly owned 1,402,141 shares of the company's stock, valued at approximately $4,150,337.36. This trade represents a 2.08% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 272,997 shares of company stock valued at $701,198. 6.80% of the stock is owned by company insiders.
Hedge Funds Weigh In On Gevo
Several institutional investors have recently bought and sold shares of the stock. NewEdge Advisors LLC raised its position in shares of Gevo by 11.0% during the 2nd quarter. NewEdge Advisors LLC now owns 92,965 shares of the energy company's stock valued at $123,000 after buying an additional 9,249 shares in the last quarter. Corient Private Wealth LLC raised its position in Gevo by 83.0% during the fourth quarter. Corient Private Wealth LLC now owns 20,950 shares of the energy company's stock valued at $42,000 after purchasing an additional 9,500 shares during the period. Cetera Investment Advisers lifted its stake in shares of Gevo by 29.0% in the 4th quarter. Cetera Investment Advisers now owns 49,137 shares of the energy company's stock valued at $98,000 after purchasing an additional 11,040 shares during the last quarter. BNP Paribas Financial Markets boosted its position in shares of Gevo by 138.1% during the second quarter. BNP Paribas Financial Markets now owns 20,927 shares of the energy company's stock valued at $28,000 after buying an additional 12,136 shares during the period. Finally, Key Client Fiduciary Advisors LLC bought a new position in shares of Gevo in the fourth quarter worth about $25,000. 35.17% of the stock is owned by hedge funds and other institutional investors.
Gevo Price Performance
GEVO stock opened at $2.30 on Friday. The business's 50-day moving average price is $2.09 and its 200-day moving average price is $2.13. The stock has a market cap of $558.49 million, a P/E ratio of -17.69 and a beta of 1.20. The company has a quick ratio of 1.58, a current ratio of 1.82 and a debt-to-equity ratio of 0.35. Gevo has a twelve month low of $0.92 and a twelve month high of $2.97.
Gevo (NASDAQ:GEVO - Get Free Report) last released its earnings results on Thursday, March 5th. The energy company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.01. The company had revenue of $45.35 million during the quarter, compared to analyst estimates of $43.52 million. Gevo had a negative net margin of 21.07% and a negative return on equity of 7.20%. On average, equities research analysts forecast that Gevo will post -0.42 EPS for the current year.
Key Headlines Impacting Gevo
Here are the key news stories impacting Gevo this week:
- Positive Sentiment: Gevo said it will double ethanol production at its North Dakota plant, shifting resources away from a planned South Dakota SAF project and increasing near‑term fuel output and revenue potential — this improves short‑term cash generation prospects. Read More.
- Neutral Sentiment: The company has shelved the South Dakota sustainable jet‑fuel project to focus on the North Dakota ethanol expansion; that reduces near‑term SAF capacity growth but clarifies capital allocation and timelines. Read More.
- Neutral Sentiment: Insider Andrew Shafer sold 5,550 shares on April 1 under a pre‑arranged Rule 10b5‑1 plan; the size is small relative to the company’s float and was planned, so it’s unlikely to signal new negative information. Read More.
- Negative Sentiment: COO Christopher Michael Ryan sold a large block of shares across March 30–31 (reported sales of ~100,000 and ~29,797 shares), materially reducing his stake; media coverage frames this as a significant unload and such sizeable insider sales have likely put downward pressure on the stock. Read More. Read More.
Gevo Company Profile
(
Get Free Report)
Gevo, Inc NASDAQ: GEVO is a renewable chemicals and biofuels company that develops and produces low-carbon alternatives to petroleum-based products. The company's core technology platform converts fermentable sugars into isobutanol, which can be further processed into sustainable aviation fuel (SAF), renewable gasoline, diesel, and jet fuel. Gevo's integrated biorefinery model combines fermentation, recovery, and downstream processing to deliver scalable, drop-in replacements for conventional fossil-derived hydrocarbons.
Gevo's primary products include isobutanol, a four-carbon alcohol used as a building block for various fuels and chemicals, and hydrocarbon fuels that meet ASTM specifications for aviation and road transport.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Gevo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gevo wasn't on the list.
While Gevo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.